|
|
Analysis of Coagulation Function and Peripheral Blood TIM-3 TAT ACE2 Levels in Patients with Acute Pancreatitis and Secondary Organ Failure |
LI Jun, WEI Guofeng, CAI Zhaohui, et al |
Hefei Second People's Hospital, Anhui Hefei 230011, China |
|
|
Abstract Objective: This study aimed to investigate alterations in coagulation function among patients with acute pancreatitis (AP) and secondary organ failure (OF) and analyze variations in peripheral blood levels of T cell immunoglobulin and mucin domain 3 (TIM-3), thrombin-antithrombin complex (TAT), and angiotensin-converting enzyme 2 (ACE2). Methods: Conducted between August 2020 and August 2022, the study involved 118 patients with AP admitted for treatment. Patient severity was assessed using the Atlanta Classification and categorized into mild (n=72) and severe (n=46) groups. Coagulation function indices and peripheral blood TIM-3, TAT, ACE2 levels were compared between the groups, investigating the relationship between secondary organ failure and these parameters. Results: Patients in the severe group exhibited significantly elevated coagulation function indices (PT, INR, APTT, and FIB) and higher peripheral blood TIM-3 and TAT levels compared to the mild group, while ACE2 levels were lower (P<0.05). Similarly, the secondary OF group showed markedly higher coagulation function indices and peripheral blood TIM-3 and TAT levels than the non-OF group, with lower ACE2 levels (P<0.05). Multifactorial analysis indicated that PT, INR, APTT, FIB, TIM-3, TAT, and ACE2 influenced the onset of secondary organ failure. The area under the ROC curve for secondary organ failure was 0.846, 0.926, 0.819, 0.862, 0.751, 0.847, and 0.858 for PT, INR, APTT, FIB, TIM-3, TAT, and ACE2, respectively. Conclusion: In patients with acute pancreatitis, abnormal coagulation and elevation of TIM-3, TAT and decreased ACE 2 in peripheral blood are strongly associated with disease severity, with potential predictive value for the risk of organ failure secondary to acute pancreatitis.
|
|
|
|
|
[1] Boxhoorn L,Voermans RP,Bouwense SA,et al.Acute pancreatitis[J].Lancet,2020,396(10252):726-734.
[2] 苟园园,姚隆,曹洁.高甘油三酯血症性急性胰腺炎凝血指标与D-二聚体水平变化及其预测疾病严重程度的价值[J].中南大学学报(医学版),2023,48(7):1050-1058.
[3] 吴蕾,高乃姝,陈桂芳,等.血小板和PT、TAT对重症急性胰腺炎并发脓毒症弥散性血管内凝血诊断及预后评估价值[J].临床误诊误治,2021,34(9):67-72.
[4] 陈曙蓓,林影,叶勇.急性胰腺炎患者血清可溶性Tim-3、炎症因子及RAAS分子检测的临床意义[J].中国现代医学杂志,2020,30(24):81-85.
[5] 何洋,丁莺,李金跃,等.急性胰腺炎患者早期CTSI评分与器官衰竭的相关性分析[J].中华急诊医学杂志,2023,32(10):1350-1352.
[6] 杜奕奇.2019年版《中国急性胰腺炎诊治指南》解读[J].医学研究生学报,2020,33(3):234-237.
[7] 吴璟奕,许志伟,毛恩强,等.改良Marshall评分和APACHE-Ⅱ评分对急性胰腺炎严重度和预后的比较[J].腹部外科,2016,29(6):424-427.
[8] Szatmary P,Grammatikopoulos T,Cai W,et al.Acute pancreatitis:diagnosis and treatment[J].Drugs,2022,82(12):1251-1276.
[9] 申秋,王俊,吴兆华.NLR、TAT和ACE2联合检测对重症急性胰腺炎病情严重程度和疾病转归的价值研究[J].现代消化及介入诊疗,2022,27(10):1310-1314.
[10] 王大良,纪晓雯,谢桃李,等.急性胰腺炎患者中性粒淋巴细胞比值及其他实验室相关指标与疾病严重程度的相关性分析[J].中国急救复苏与灾害医学杂志,2023,18(1):72-77.
[11] 黄鑫,何文华.重症急性胰腺炎门静脉血栓形成及其预防研究进展[J].中国实用内科杂志,2018,38(11):1104-1106.
[12] 柳林,金钧,黄芳,等.凝血酶-抗凝血酶复合物与红细胞分布宽度检测在急性胰腺炎严重程度及预后评估中的价值[J].陕西医学杂志,2021,50(6):742-746.
[13] Zhang Y,Ma CJ,Wang JM,et al.Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes[J].Leukoc Biol,2012,91(2):189-96.
[14] Ren F,Li J,Jiang X,et al.Plasma soluble Tim-3 emerges as an inhibitor in sepsis:sepsis contrary to membrane Tim-3 on monocytes[J].Tissue Antigens,2015,86(5):325-32.
[15] 胡小丽,刘哲,邓茂林.SAA、CRP和ACE2水平与急性胰腺炎患者病情严重程度的关系[J].西部医学,2021,33(3):440-443. |
|
|
|